i10 Productivity
Rankings

AstraZeneca, Sweden Scientists i10 Productivity Rankings 2024

Productivity Rankings is a unique service offered only by “AD Scientific Index”. This is a ranking system derived from the i10 index in order to show the productivity of the scientist in publishing scientific articles of value. Productivity Rankings is an instrument that lists productive scientists in a given area, discipline, university, and country and can guide the development of meaningful incentives and academic policies. The world rankings, regional rankings, and university rankings of scientists in this table are developed based on the total i10 index. Click for "last 6 years' i10 index"Also see: Universities Rankings 2024 (Sort by : Total i10 Index)  and Universities Rankings 2024 (Sort by : Last 6 Years i10 Index)

i10 Productivity Rankings
University / Institution:
# 26
Country:
# 2,055
Region:
# 53,799
World:
# 147,210
i10 Index
Total:
82
Last 6 Year:
47
Last 6 Year/Total:
0.573
H-Index
Total:
35
Last 6 Year:
21
Last 6 Year/Total:
0.600
Citation
Total:
4,366
Last 6 Year:
1,658
Last 6 Year/Total:
0.380
Cardiovascular
Drug Discovery & Development
i10 Productivity Rankings
University / Institution:
# 27
Country:
# 2,089
Region:
# 54,809
World:
# 149,917
i10 Index
Total:
81
Last 6 Year:
39
Last 6 Year/Total:
0.481
H-Index
Total:
48
Last 6 Year:
21
Last 6 Year/Total:
0.438
Citation
Total:
7,957
Last 6 Year:
1,459
Last 6 Year/Total:
0.183
i10 Productivity Rankings
University / Institution:
# 28
Country:
# 2,137
Region:
# 56,306
World:
# 154,014
i10 Index
Total:
79
Last 6 Year:
61
Last 6 Year/Total:
0.772
H-Index
Total:
35
Last 6 Year:
26
Last 6 Year/Total:
0.743
Citation
Total:
4,447
Last 6 Year:
3,190
Last 6 Year/Total:
0.717
i10 Productivity Rankings
University / Institution:
# 29
Country:
# 2,148
Region:
# 56,564
World:
# 154,698
i10 Index
Total:
79
Last 6 Year:
48
Last 6 Year/Total:
0.608
H-Index
Total:
44
Last 6 Year:
23
Last 6 Year/Total:
0.523
Citation
Total:
6,448
Last 6 Year:
2,418
Last 6 Year/Total:
0.375
replicability
reproduciblity
in-vivo
experimental design
sex bias
i10 Productivity Rankings
University / Institution:
# 30
Country:
# 2,179
Region:
# 57,177
World:
# 156,261
i10 Index
Total:
78
Last 6 Year:
66
Last 6 Year/Total:
0.846
H-Index
Total:
47
Last 6 Year:
35
Last 6 Year/Total:
0.745
Citation
Total:
16,136
Last 6 Year:
11,205
Last 6 Year/Total:
0.694
From directed protein evolution to experimental medicine
i10 Productivity Rankings
University / Institution:
# 31
Country:
# 2,300
Region:
# 60,328
World:
# 164,980
i10 Index
Total:
75
Last 6 Year:
62
Last 6 Year/Total:
0.827
H-Index
Total:
45
Last 6 Year:
31
Last 6 Year/Total:
0.689
Citation
Total:
7,725
Last 6 Year:
3,472
Last 6 Year/Total:
0.449
i10 Productivity Rankings
University / Institution:
# 32
Country:
# 2,356
Region:
# 61,905
World:
# 169,016
i10 Index
Total:
74
Last 6 Year:
45
Last 6 Year/Total:
0.608
H-Index
Total:
45
Last 6 Year:
28
Last 6 Year/Total:
0.622
Citation
Total:
6,960
Last 6 Year:
3,564
Last 6 Year/Total:
0.512
i10 Productivity Rankings
University / Institution:
# 33
Country:
# 2,372
Region:
# 62,372
World:
# 170,171
i10 Index
Total:
73
Last 6 Year:
72
Last 6 Year/Total:
0.986
H-Index
Total:
37
Last 6 Year:
37
Last 6 Year/Total:
1.000
Citation
Total:
5,193
Last 6 Year:
4,746
Last 6 Year/Total:
0.914
i10 Productivity Rankings
University / Institution:
# 34
Country:
# 2,410
Region:
# 63,244
World:
# 172,503
i10 Index
Total:
73
Last 6 Year:
39
Last 6 Year/Total:
0.534
H-Index
Total:
36
Last 6 Year:
22
Last 6 Year/Total:
0.611
Citation
Total:
4,328
Last 6 Year:
1,970
Last 6 Year/Total:
0.455
i10 Productivity Rankings
University / Institution:
# 35
Country:
# 2,525
Region:
# 66,065
World:
# 179,968
i10 Index
Total:
70
Last 6 Year:
66
Last 6 Year/Total:
0.943
H-Index
Total:
38
Last 6 Year:
31
Last 6 Year/Total:
0.816
Citation
Total:
4,507
Last 6 Year:
3,151
Last 6 Year/Total:
0.699
i10 Productivity Rankings
University / Institution:
# 36
Country:
# 2,531
Region:
# 66,169
World:
# 180,286
i10 Index
Total:
70
Last 6 Year:
62
Last 6 Year/Total:
0.886
H-Index
Total:
40
Last 6 Year:
31
Last 6 Year/Total:
0.775
Citation
Total:
5,097
Last 6 Year:
2,908
Last 6 Year/Total:
0.571
Precision Medicine
Drug Discovery
Digital Health
Computational Biology
Translational Bioinformatics
i10 Productivity Rankings
University / Institution:
# 37
Country:
# 2,539
Region:
# 66,249
World:
# 180,573
i10 Index
Total:
70
Last 6 Year:
59
Last 6 Year/Total:
0.843
H-Index
Total:
38
Last 6 Year:
33
Last 6 Year/Total:
0.868
Citation
Total:
6,500
Last 6 Year:
5,012
Last 6 Year/Total:
0.771
Diabetes
Cardiovascular disease
Heart failure
Kidney disease
Hypertension
i10 Productivity Rankings
University / Institution:
# 38
Country:
# 2,540
Region:
# 66,253
World:
# 180,581
i10 Index
Total:
70
Last 6 Year:
59
Last 6 Year/Total:
0.843
H-Index
Total:
37
Last 6 Year:
31
Last 6 Year/Total:
0.838
Citation
Total:
5,776
Last 6 Year:
4,173
Last 6 Year/Total:
0.722
i10 Productivity Rankings
University / Institution:
# 39
Country:
# 2,548
Region:
# 66,392
World:
# 180,912
i10 Index
Total:
70
Last 6 Year:
55
Last 6 Year/Total:
0.786
H-Index
Total:
51
Last 6 Year:
28
Last 6 Year/Total:
0.549
Citation
Total:
37,861
Last 6 Year:
7,894
Last 6 Year/Total:
0.208
Chemical Engineering
Process Engineering
Pharmaceutical Engineering
Modelling
Simulation
i10 Productivity Rankings
University / Institution:
# 40
Country:
# 2,554
Region:
# 66,511
World:
# 181,233
i10 Index
Total:
70
Last 6 Year:
52
Last 6 Year/Total:
0.743
H-Index
Total:
31
Last 6 Year:
23
Last 6 Year/Total:
0.742
Citation
Total:
3,222
Last 6 Year:
1,779
Last 6 Year/Total:
0.552
i10 Productivity Rankings
University / Institution:
# 41
Country:
# 2,567
Region:
# 66,819
World:
# 182,030
i10 Index
Total:
70
Last 6 Year:
40
Last 6 Year/Total:
0.571
H-Index
Total:
39
Last 6 Year:
21
Last 6 Year/Total:
0.538
Citation
Total:
8,272
Last 6 Year:
2,199
Last 6 Year/Total:
0.266
Sustainability
Environmental Risk Assessment
Persistence Assessment
Antimicrobial Resistance
Biodegradability
i10 Productivity Rankings
University / Institution:
# 42
Country:
# 2,604
Region:
# 67,497
World:
# 184,043
i10 Index
Total:
69
Last 6 Year:
57
Last 6 Year/Total:
0.826
H-Index
Total:
40
Last 6 Year:
35
Last 6 Year/Total:
0.875
Citation
Total:
9,475
Last 6 Year:
5,071
Last 6 Year/Total:
0.535
Genetics
Cardiovascular Science
Physiology
Gene Expression
Cell survival
i10 Productivity Rankings
University / Institution:
# 43
Country:
# 2,612
Region:
# 67,824
World:
# 184,944
i10 Index
Total:
69
Last 6 Year:
47
Last 6 Year/Total:
0.681
H-Index
Total:
36
Last 6 Year:
27
Last 6 Year/Total:
0.750
Citation
Total:
5,284
Last 6 Year:
1,874
Last 6 Year/Total:
0.355
i10 Productivity Rankings
University / Institution:
# 44
Country:
# 2,669
Region:
# 69,463
World:
# 189,162
i10 Index
Total:
68
Last 6 Year:
36
Last 6 Year/Total:
0.529
H-Index
Total:
39
Last 6 Year:
19
Last 6 Year/Total:
0.487
Citation
Total:
7,822
Last 6 Year:
1,388
Last 6 Year/Total:
0.177
Lipoproteins
Coronary artery disease
Heart failure
Inflammation
Cardiovascular disease
i10 Productivity Rankings
University / Institution:
# 45
Country:
# 2,743
Region:
# 71,337
World:
# 194,288
i10 Index
Total:
66
Last 6 Year:
60
Last 6 Year/Total:
0.909
H-Index
Total:
36
Last 6 Year:
30
Last 6 Year/Total:
0.833
Citation
Total:
4,604
Last 6 Year:
3,369
Last 6 Year/Total:
0.732
Drug Discovery
Medicinal Chemistry
Organic Chemistry
Pharmacology
i10 Productivity Rankings
University / Institution:
# 46
Country:
# 2,788
Region:
# 72,290
World:
# 196,819
i10 Index
Total:
66
Last 6 Year:
32
Last 6 Year/Total:
0.485
H-Index
Total:
39
Last 6 Year:
17
Last 6 Year/Total:
0.436
Citation
Total:
4,497
Last 6 Year:
857
Last 6 Year/Total:
0.191
i10 Productivity Rankings
University / Institution:
# 47
Country:
# 2,821
Region:
# 73,240
World:
# 199,417
i10 Index
Total:
65
Last 6 Year:
48
Last 6 Year/Total:
0.738
H-Index
Total:
32
Last 6 Year:
26
Last 6 Year/Total:
0.813
Citation
Total:
8,713
Last 6 Year:
4,688
Last 6 Year/Total:
0.538
i10 Productivity Rankings
University / Institution:
# 48
Country:
# 2,840
Region:
# 73,682
World:
# 200,559
i10 Index
Total:
65
Last 6 Year:
34
Last 6 Year/Total:
0.523
H-Index
Total:
35
Last 6 Year:
25
Last 6 Year/Total:
0.714
Citation
Total:
4,281
Last 6 Year:
2,435
Last 6 Year/Total:
0.569
i10 Productivity Rankings
University / Institution:
# 49
Country:
# 2,858
Region:
# 74,234
World:
# 202,116
i10 Index
Total:
64
Last 6 Year:
57
Last 6 Year/Total:
0.891
H-Index
Total:
40
Last 6 Year:
29
Last 6 Year/Total:
0.725
Citation
Total:
4,547
Last 6 Year:
2,706
Last 6 Year/Total:
0.595
i10 Productivity Rankings
University / Institution:
# 50
Country:
# 2,896
Region:
# 75,461
World:
# 205,233
i10 Index
Total:
64
Last 6 Year:
20
Last 6 Year/Total:
0.313
H-Index
Total:
38
Last 6 Year:
14
Last 6 Year/Total:
0.368
Citation
Total:
6,407
Last 6 Year:
1,465
Last 6 Year/Total:
0.229
AD Scientific Index - World Scientists i10 Productivity Rankings - 2024 i10 INDEX H INDEX CITATION
University Country Region World Name Country University / Institution Subject Total Last 6 Year Last 6 year/total Total Last 6 year Last 6 year/total Total Last 6 year Last 6 year/total
26 2,055 53,799 147,210
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Chemical Sciences

Chemistry |

82 47 0.573 35 21 0.600 4,366 1,658 0.380
27 2,089 54,809 149,917
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

Cardiovascular | Drug Discovery & Development |

81 39 0.481 48 21 0.438 7,957 1,459 0.183
28 2,137 56,306 154,014
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

Early Phase Oncology |

79 61 0.772 35 26 0.743 4,447 3,190 0.717
29 2,148 56,564 154,698
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

79 48 0.608 44 23 0.523 6,448 2,418 0.375
30 2,179 57,177 156,261
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Mathematical Sciences

replicability | reproduciblity | in-vivo | experimental design | sex bias |

78 66 0.846 47 35 0.745 16,136 11,205 0.694
31 2,300 60,328 164,980
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Biological Science

From directed protein evolution to experimental medicine |

75 62 0.827 45 31 0.689 7,725 3,472 0.449
32 2,356 61,905 169,016
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

74 45 0.608 45 28 0.622 6,960 3,564 0.512
33 2,372 62,372 170,171
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Molecular Biology & Genetics

bioinformatics | drug discovery | AI/ML |

73 72 0.986 37 37 1.000 5,193 4,746 0.914
34 2,410 63,244 172,503
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Chemical Sciences

Medicinal Chemistry | Oncology |

73 39 0.534 36 22 0.611 4,328 1,970 0.455
35 2,525 66,065 179,968
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

MS imaging | molecular imaging |

70 66 0.943 38 31 0.816 4,507 3,151 0.699
Adscientificindex

Click for INSTITUTIONAL BULK REGISTRATION and PREMIUM MEMBERSHIP advantages

Adscientificindex
36 2,531 66,169 180,286
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

70 62 0.886 40 31 0.775 5,097 2,908 0.571
37 2,539 66,249 180,573
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Molecular Biology & Genetics

Precision Medicine | Drug Discovery | Digital Health | Computational Biology | Translational Bioinformatics |

70 59 0.843 38 33 0.868 6,500 5,012 0.771
38 2,540 66,253 180,581
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

Diabetes | Cardiovascular disease | Heart failure | Kidney disease | Hypertension |

70 59 0.843 37 31 0.838 5,776 4,173 0.722
39 2,548 66,392 180,912
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Molecular Biology & Genetics

genomics | genetics | oncology | DNA sequencing | bioinformatics |

70 55 0.786 51 28 0.549 37,861 7,894 0.208
40 2,554 66,511 181,233
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Engineering & Technology / Chemical Engineering

Chemical Engineering | Process Engineering | Pharmaceutical Engineering | Modelling | Simulation |

70 52 0.743 31 23 0.742 3,222 1,779 0.552
41 2,567 66,819 182,030
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

pharmaceutical research | drug discovery | QSAR |

70 40 0.571 39 21 0.538 8,272 2,199 0.266
42 2,604 67,497 184,043
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

Sustainability | Environmental Risk Assessment | Persistence Assessment | Antimicrobial Resistance | Biodegradability |

69 57 0.826 40 35 0.875 9,475 5,071 0.535
43 2,612 67,824 184,944
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Molecular Biology & Genetics

Genetics | Cardiovascular Science | Physiology | Gene Expression | Cell survival |

69 47 0.681 36 27 0.750 5,284 1,874 0.355
44 2,669 69,463 189,162
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Biological Science

Proteomics | Metabolomics | Mass Spectrometry |

68 36 0.529 39 19 0.487 7,822 1,388 0.177
45 2,743 71,337 194,288
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

Lipoproteins | Coronary artery disease | Heart failure | Inflammation | Cardiovascular disease |

66 60 0.909 36 30 0.833 4,604 3,369 0.732
46 2,788 72,290 196,819
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Chemical Sciences

Drug Discovery | Medicinal Chemistry | Organic Chemistry | Pharmacology |

66 32 0.485 39 17 0.436 4,497 857 0.191
47 2,821 73,240 199,417
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

65 48 0.738 32 26 0.813 8,713 4,688 0.538
48 2,840 73,682 200,559
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Medical and Health Sciences / Cardiovascular Surgery

Heart failure | drug discovery | cardiac regeneration | stem cell |

65 34 0.523 35 25 0.714 4,281 2,435 0.569
49 2,858 74,234 202,116
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Biological Science

Ecotoxicology | 3Rs | Environmental Safety |

64 57 0.891 40 29 0.725 4,547 2,706 0.595
50 2,896 75,461 205,233
Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

arrhythmias | heart failure |

64 20 0.313 38 14 0.368 6,407 1,465 0.229